Total investments 13
Average round size 
$50M
The average size of a deal this fund participated in
Portfolio companies 12
Rounds per year 0.93
Lead investments 2
Follow on index
0.08How often the fund supports its portfolio startups at next rounds
Key employees Soon
Shanghai, China Related Funds
Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CS Capital:
Typical Co-investors
CS Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CS Capital:
There are no funds here. If we find new data, we will add it here.
Look at other 50 related and similar funds Collapse list ↓
| Fund Name | Location |
| Akka Venture | France, Ile-de-France, Paris |
| Aon plc | England, London, United Kingdom |
| Arkansas Development Finance Authority | Arkansas, Little Rock, United States |
| Brain Games | - |
| Chicago Venture Summit | Chicago, Illinois, United States |
| Commonwealth Research Commercialization Fund | - |
| Cosmo Bio | Japan, Tokyo |
| Leumi Partners | Israel, Tel Aviv, Tel Aviv District |
| MK Energy and Infrastructure | Connecticut, Stamford, United States |
| Shanghai Jinyi Keji Touzi Youxian Gongsi | China, Chongming, Chongming District |
| The Batchery Angels | - |
| TSK | Asturias, Gijón, Spain |
| University of Chicago New Venture Challenge | Chicago, Illinois, United States |
| View Worldwide Technology | China, Guangdong, Zhuhai |
| WDI GROUP | Japan, Tokyo |
| Weifang Hongtu Ziben | China, Japan, Kagoshima Prefecture |
| Winning Health Technology Group | China, Shanghai |
| Zhejiang Dening Industrial | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Hengyu Biotechnology | $30M | 11 Mar 2024 | Jiaxing, Zhejiang, China | ||
Weimu Medical | $15M | 06 Dec 2023 | Shanghai, Shanghai, China | ||
Biointron | $77M | 31 Aug 2022 | Shanghai, Shanghai, China | ||
Porton Advanced Solutions | $80M | 21 Aug 2022 | Suzhou, Jiangsu, China | ||
Future Vision | 27 Jun 2022 | Shanghai, Shanghai, China | |||
InxMed | $50M | 03 Mar 2022 | Shanghai, China | ||
Tavotek Biotherapeutics | $35M | 18 Nov 2021 | Lower Gwynedd Township, Pennsylvania, United States | ||
Biointron | 28 Jul 2021 | Shanghai, Shanghai, China | |||
Ab&B Biotech | $92M | 16 Jul 2021 | Taizhou, Jiangsu, China |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
To post a comment or write a complain, please sign in with LinkedIn
Review
- No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Do you represent CS Capital?
Get access to manage this page
Found incorrect info? Let us know!
Total investments 13
Average round size 50M
Rounds per year 0.93
Peak activity year 2022
Lead investments 2
Follow on index 0.08
Group Appearance index 0.85
Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Hengyu Biotechnology | $30M | 11 Mar 2024 | Jiaxing, Zhejiang, China | ||
Weimu Medical | $15M | 06 Dec 2023 | Shanghai, Shanghai, China | ||
Biointron | $77M | 31 Aug 2022 | Shanghai, Shanghai, China | ||
Porton Advanced Solutions | $80M | 21 Aug 2022 | Suzhou, Jiangsu, China | ||
Future Vision | 27 Jun 2022 | Shanghai, Shanghai, China | |||
InxMed | $50M | 03 Mar 2022 | Shanghai, China | ||
Tavotek Biotherapeutics | $35M | 18 Nov 2021 | Lower Gwynedd Township, Pennsylvania, United States | ||
Biointron | 28 Jul 2021 | Shanghai, Shanghai, China | |||
Ab&B Biotech | $92M | 16 Jul 2021 | Taizhou, Jiangsu, China |
